Agility Radiation Therapy Treatment For Cancer Receives U.S. 510(k) Clearance
Monday, June 25, 2012 - 05:10
in Health & Medicine
Using 160 high-resolution tungsten leaves and dramatically faster leaf movement, Elekta’s new Agility multi-leaf collimator (MLC) radiation therapy treatment for cancer patients recently received 510(k) clearance (K121328) from the U.S. Food and Drug Administration (FDA), enabling U.S. medical centers to use it for patients with cancer. An MLC is device made up of numerous, individual tungsten “leaves,” which shape beams of therapeutic radiation that are delivered from different angles around the patient. Using twice the number of leaves typical of many standard MLC’s, Agility precisely delivers radiation to the unique contours of the tumor, while reducing the risk of exposure to healthy tissue. read more